325 related articles for article (PubMed ID: 6124112)
1. Anti-human cytomegalovirus nuclear antigen antibodies of different immunoglobulin classes.
Czeglédy J; Gergely L; Váczi L; Vályi-Nagy T
Acta Virol; 1982 Jan; 26(1-2):73-8. PubMed ID: 6124112
[TBL] [Abstract][Full Text] [Related]
2. Demonstration of EBNA (Epstein-Barr virus nuclear antigen) antibodies of different immunoglobulin classes.
Czeglédy J; Gergely L; Váczi L; Szalka A
Acta Microbiol Acad Sci Hung; 1978; 25(4):237-43. PubMed ID: 224651
[TBL] [Abstract][Full Text] [Related]
3. Complement-fixing antibodies to human cytomegalovirus induced early nuclear antigens in mononucleosis.
Gergely L; Gzeglédy J; Váczi L
Med Microbiol Immunol; 1981; 170(2):99-108. PubMed ID: 6275252
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus and cytomegalovirus antibodies in infectious mononucleosis.
Gergely L; Czeglédy J; Szalka A; Váczi L; Binder L
Acta Microbiol Acad Sci Hung; 1977; 24(1):13-9. PubMed ID: 201153
[TBL] [Abstract][Full Text] [Related]
5. Contribution to rapid diagnosis of infectious mononucleosis.
Franková V; Stanková M; Kouba K; Hásková V; Pavlík E
Acta Virol; 1986 May; 30(3):234-42. PubMed ID: 2874728
[TBL] [Abstract][Full Text] [Related]
6. Altered humoral immunity against cytomegalovirus and Epstein-Barr virus without detectable virus antigens and virus-DNA in the glomeruli of patients with IGA nephropathy in remission phase.
Nagy J; Haikin H; Sarov B; Háber A; Kun L; Sarov I
Acta Microbiol Immunol Hung; 1995; 42(2):179-87. PubMed ID: 7551711
[TBL] [Abstract][Full Text] [Related]
7. Immunoreactivation of Epstein-Barr virus due to cytomegalovirus primary infection.
Aalto SM; Linnavuori K; Peltola H; Vuori E; Weissbrich B; Schubert J; Hedman L; Hedman K
J Med Virol; 1998 Nov; 56(3):186-91. PubMed ID: 9783683
[TBL] [Abstract][Full Text] [Related]
8. Sensitive method to detect non-complement-fixing antibodies to Epstein-Barr virus nuclear antigne.
Schmitz H; Kampa D; Heidenreich W
Int J Cancer; 1975 Dec; 16(6):1030-4. PubMed ID: 172458
[TBL] [Abstract][Full Text] [Related]
9. [A comparison of the detection of IgM antibodies against the viral capsid antigen (VCA) of EBV (Epstein-Barr virus) in various groups of patients, using indirect immunofluorescence, indirect ELISA and reverse ELISA. Study of the diagnostic efficacy of the anti-VCA EBV IgM ELISA-VIDITEST kit].
Pumannová M; Rezbová M; Svecová M; Hrbácková H; Novotná M; Ochotná J; Roubalová K
Klin Mikrobiol Infekc Lek; 2004 Aug; 10(4):186-90. PubMed ID: 15328576
[TBL] [Abstract][Full Text] [Related]
10. The significance of serum IgM IgA and IgG antibodies specific for Epstein-Barr virus as determined by immunoperoxidase assay in the rapid diagnosis of infectious mononucleosis.
Hadar T; Margalith M; Sagiv E; Sarov B; Sarov I
Isr J Med Sci; 1995 May; 31(5):280-3. PubMed ID: 7759222
[TBL] [Abstract][Full Text] [Related]
11. High incidence of elevated antibody titers to Epstein-Barr virus in patients with uveitis.
Touge C; Agawa H; Sairenji T; Inoue Y
Arch Virol; 2006 May; 151(5):895-903. PubMed ID: 16362642
[TBL] [Abstract][Full Text] [Related]
12. Humoral immune response in Epstein-Barr virus infections. I. Elevated serum concentration of the IgG1 subclass in infectious mononucleosis and nasopharyngeal carcinoma.
Kaschka WP; Hilgers R; Skvaril F
Clin Exp Immunol; 1982 Jul; 49(1):149-56. PubMed ID: 6290114
[TBL] [Abstract][Full Text] [Related]
13. Cross-reactivity of Epstein-Barr virus-specific immunoglobulin M antibodies with cytomegalovirus antigens containing glycine homopolymers.
Lang D; Vornhagen R; Rothe M; Hinderer W; Sonneborn HH; Plachter B
Clin Diagn Lab Immunol; 2001 Jul; 8(4):747-56. PubMed ID: 11427421
[TBL] [Abstract][Full Text] [Related]
14. [Correlation between the presence of cytomegalovirus antibodies and antigen in blood leukocytes for the diagnosis of primary active infection].
Gutiérrez J; Piédrola G; Maroto C
Rev Med Chil; 1998 May; 126(5):533-7. PubMed ID: 9731435
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the occurrence of antibodies to human cytomegalovirus as demonstrated by complement fixation, enzyme-linked-immunosorbent assay and indirect immunofluorescence.
Landini MP; Re MC; Coppolecchia P
Boll Ist Sieroter Milan; 1982; 61(4):320-3. PubMed ID: 6100235
[TBL] [Abstract][Full Text] [Related]
16. Immunoglobulin M to the membrane of uninfected fibroblasts in primary human cytomegalovirus infections.
Revello MG; Percivalle E; Gerna G
Microbiologica; 1986 Apr; 9(2):127-38. PubMed ID: 3012285
[TBL] [Abstract][Full Text] [Related]
17. [Relationship between human cytomegalovirus infection and soluble interleukin-2 receptor level].
Cao Y; Li A
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Sep; 11(3):256-8. PubMed ID: 15617342
[TBL] [Abstract][Full Text] [Related]
18. Cytomegalovirus in the mononucleosis syndrome in children.
Najberg G; Jankowski M; Krotochwil-Skrzypkowa M; Gut W
Acta Microbiol Pol; 1985; 34(2):137-44. PubMed ID: 2412401
[TBL] [Abstract][Full Text] [Related]
19. Primary cytomegalovirus infection in an outpatient setting--laboratory markers and clinical aspects.
Just-Nübling G; Korn S; Ludwig B; Stephan C; Doerr HW; Preiser W
Infection; 2003 Oct; 31(5):318-23. PubMed ID: 14556056
[TBL] [Abstract][Full Text] [Related]
20. Cytomegalovirus antibodies in renal transplant recipients.
Jankowski M; Gut W; Nawrocka E; Gradowska L; Roncewicz Z; Rowińska D
Acta Microbiol Pol; 1982; 31(3-4):279-85. PubMed ID: 6189377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
